Target intelligence / Profile preview

Undecaprenyl phosphate (C55-P)

Target
C55-P
Molecular classification
Other, Lipid, Transporter
01

Overview

Undecaprenyl phosphate, also known as bactoprenyl phosphate, is an essential C55 isoprenoid lipid that functions as a membrane-bound carrier in bacteria (Source: PubMed, PMID: 16299104). Its primary role is to transport hydrophilic precursors of the cell wall, such as peptidoglycan subunits (Lipid II), across the cytoplasmic membrane to the site of assembly (Source: Nature, doi:10.1038/nature14098). This lipid carrier is recycled through a cycle of phosphorylation and dephosphorylation; specifically, undecaprenyl pyrophosphate must be converted back to undecaprenyl phosphate to initiate a new round of transport (Source: JBC, doi:10.1074/jbc.M110.155010). This recycling process is the target of the antibiotic bacitracin, which forms a complex with the pyrophosphate form in the presence of divalent cations, thereby halting cell wall synthesis and leading to bacterial cell death (Source: StatPearls, NBK536977). Because the undecaprenyl phosphate cycle is unique to prokaryotes and vital for maintaining structural integrity, it is a highly validated target for the development of narrow and broad-spectrum antibacterial agents. Newer antibiotics like teixobactin also interact with this pathway by binding to the lipid-linked precursors, effectively sequestering the carrier and preventing its reuse (Source: Nature, doi:10.1038/nature14098). The essentiality of this carrier across diverse bacterial species makes it a resilient target against the development of resistance, as seen with the slow emergence of resistance to drugs like teixobactin.

Other names
Bactoprenyl phosphateUndecaprenyl pyrophosphateC55-isoprenyl phosphateLipid carrierC55-PP
02

Mechanism of action

Inhibition of lipid carrier recycling by binding to undecaprenyl pyrophosphate and preventing dephosphorylation (e.g., Bacitracin), or by sequestering the lipid carrier to prevent precursor loading (e.g., Friulimicin B).

03

Biological functions

OtherCell wall biosynthesisPeptidoglycan transportTeichoic acid synthesisLipopolysaccharide O-antigen transport
04

Disease associations

Infection
05

Safety considerations

Nephrotoxicity (systemic use)Contact dermatitis (topical use)Limited systemic bioavailability
06

Interacting drugs

Bacitracin

4 more in the full profile.

07

Biomarkers

Bacterial loadPeptidoglycan synthesis inhibition

Beyond the preview

Go deeper on Undecaprenyl phosphate (C55-P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl phosphate (C55-P).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call